JP2002542248A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542248A5
JP2002542248A5 JP2000612301A JP2000612301A JP2002542248A5 JP 2002542248 A5 JP2002542248 A5 JP 2002542248A5 JP 2000612301 A JP2000612301 A JP 2000612301A JP 2000612301 A JP2000612301 A JP 2000612301A JP 2002542248 A5 JP2002542248 A5 JP 2002542248A5
Authority
JP
Japan
Prior art keywords
pharmaceuticals
prevention
treatment
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000612301A
Other languages
English (en)
Other versions
JP2002542248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/003388 external-priority patent/WO2000063211A1/en
Publication of JP2002542248A publication Critical patent/JP2002542248A/ja
Publication of JP2002542248A5 publication Critical patent/JP2002542248A5/ja
Withdrawn legal-status Critical Current

Links

Description

【請求項9】 請求項1に記載の化合物および/または薬理学的に認容性の塩と一緒に汎用の薬理学的賦形剤および/または担持剤を含有する、胃腸疾患を予防および治療する医薬品。
JP2000612301A 1999-04-17 2000-04-14 ハロアルコキシイミダゾナフチリジン Withdrawn JP2002542248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107688.6 1999-04-17
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (2)

Publication Number Publication Date
JP2002542248A JP2002542248A (ja) 2002-12-10
JP2002542248A5 true JP2002542248A5 (ja) 2007-05-10

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000612301A Withdrawn JP2002542248A (ja) 1999-04-17 2000-04-14 ハロアルコキシイミダゾナフチリジン

Country Status (12)

Country Link
US (1) US6503923B1 (ja)
EP (1) EP1173439B1 (ja)
JP (1) JP2002542248A (ja)
AT (1) ATE240956T1 (ja)
AU (1) AU3966600A (ja)
CA (1) CA2370231A1 (ja)
DE (1) DE60002855T2 (ja)
DK (1) DK1173439T3 (ja)
ES (1) ES2199810T3 (ja)
PT (1) PT1173439E (ja)
SI (1) SI1173439T1 (ja)
WO (1) WO2000063211A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
PL366658A1 (en) 2001-08-02 2005-02-07 Altana Pharma Ag Tricyclic epoxides
BR0211620A (pt) * 2001-08-03 2004-08-24 Altana Pharma Ag Imidazopiridinas substituìdas por alquila para o tratamento de distúrbios gastrointestinais
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
EA008375B1 (ru) 2002-02-15 2007-04-27 Алтана Фарма Аг Трициклические n-ацильные соединения
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA05005117A (es) 2002-11-19 2005-07-01 Altana Pharma Ag Imidazopiridinas 8-sustituidas.
US20060154954A1 (en) * 2003-02-17 2006-07-13 Altana Pharma Ag Combinations and use of selected pharmaceutically active compounds
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
MXPA05012463A (es) * 2003-05-27 2006-01-30 Altana Pharma Ag Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
WO2006037748A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
EE04677B1 (et) * 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Similar Documents

Publication Publication Date Title
JP2002542248A5 (ja)
NO2020019I1 (no) Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt
USD533668S1 (en) Magnetic therapeutic elbow brace
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
NO2020007I1 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
JP2003503454A5 (ja)
USD471628S1 (en) Medical vial
NO2012009I1 (no) Kombinasjonsprodukt av saxaglipin og metformin og farmasøytisk akseptable salter frav, herunder HCI saltene av saxaglipin og metformin
USD488478S1 (en) Front face of a combined personal digital assistant and navigation device
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
WO2006102446A3 (en) Multi-particulate, modified-released colonic composition
HK1081855A1 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
ID30225A (id) Tablet matriks yang memungkinkan pelepasan yang diperlama dari gliklazida setelah pemberian secara oral
JP2005507892A5 (ja)
JP2003526626A5 (ja)
JP2002522501A5 (ja)
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
JP2001513504A5 (ja)
USD438297S1 (en) Deodorizing apparatus for personal use
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
USD470329S1 (en) Bed
USD657863S1 (en) Mask